Presenter: Mark Disselkoen, MSSW, LCSW, LCADC
The primary goal of this online course is to create awareness about the three medications approved by the FDA for the treatment of individuals with an Opioid Use Disorder. Information will be provided on screening and assessment to determine individuals who are best suited for Medication Assisted Treatment and psychosocial evidenced based practice approaches for effective treatment in combination with MAT. Additionally, each medication including Methadone, Buprenorphine, Buprenorphine/Naloxone and Naltrexone will be discussed related to how each medication works and research on effectiveness of the medications. Finally, information will be presented related to Federal and State regulations impacting the utilization of MAT in Nevada.
Continuing Education Units: 3 CEUs
This training is approved for CEUs by the following professional organizations:
Presentation materials are not for reproduction or distribution without specific written authorization. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of CASAT.
|End Date||12-31-2022 PDT|
|Registration Start Date||07-29-2021 PDT|
|Event Time Zone||PDT|
|Cut Off Date||12-31-2022 PDT|